AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 19819042
Drug: Cinitapride 1mg
RxNorm normalized name: cinitapride
DrugBank: Cinitapride (DB08810)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinitapride 1mg oral solution t.i.d for 4 weeks
Trial: 16415304
Drug: Tibolone (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tibolone (2.5 mg daily)
Trial: 7534166
Drug: Alfuzosin 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfuzosin 7.5 mg/day for 30 days
Trial: 31618498
Drug: Ointment containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ointment containing Ceratothoa oestroides extract and cefaclor
Trial: 31098654
Drug: n-3 polyunsaturated
RxNorm normalized name: Omega-3 (n-3) polyunsaturated fatty acids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 polyunsaturated fatty acids (n-3 PUFA) 2.2 g/day
Trial: 29069156
Drug: OTC non-hydrogen
RxNorm normalized name: Hydrogen
DrugBank: Hydrogen (DB15127)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OTC non-hydrogen peroxide bleaching agent (iWhite Instant)
Trial: 29069156
Drug: Placebo (identically
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (identically composed product without active agents)
Trial: 25425023
Drug: Zoledronate administration
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronate administration after radiotherapy (Group A)
Trial: 25425023
Drug: Zoledronate administration
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronate administration prior to radiotherapy (Group B)
Trial: 16148616
Drug: Valsartan (160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan (160 mg/day) administered at bedtime
Trial: 12680160
Drug: Marimastat 10
RxNorm normalized name: Marimastat
DrugBank: Marimastat (DB00786)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marimastat 10 mg b.d. for up to two years
Trial: 1796656
Drug: Diclofenac (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac (2 x 50 mg daily)
Trial: 1796656
Drug: Indomethacin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (3 x 25 mg daily)
Trial: 6880546
Drug: Regional intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regional intravenous sympathetic block with guanethidine (RGB)
Trial: 30883596
Drug: Carbohydrate intake
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate intake (0.2 g/kg every 15 minutes) during exercise with bananas (Cavendish, Mini-yellow) and a 6% sugar beverage
Trial: 20001426
Drug: Synthetic cannabinoids
RxNorm normalized name: Synthetic camphor
DrugBank: Synthetic camphor (DB14156)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synthetic cannabinoids (nabilone, dronabinol, combination of synthetic Delta9‐THC and cannabidiol)
Trial: 12884888
Drug: Imipramine maintenance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine maintenance treatment (n = 29)
Trial: 7838190
Drug: 1 percent
RxNorm normalized name: CAPSAICIN 0.1 g in 100 g TOPICAL CREAM [Capsaicin 0.1 Percent]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 percent solution of silver nitrate (n = 929)
Trial: 21652616
Drug: i-gel™ and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i-gel™ and sILMA™
Trial: 12670672
Drug: DMSO 50%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DMSO 50% applied five times daily to the affected extremity
Trial: 12670672
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) 600mg effervescent tablets three times daily
Trial: 8557899
Drug: Nifedipine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (20 mg twice daily)
Trial: 15566660
Drug: Sheng Ban
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sheng Ban Recipe (SBR) plus common treatment
Trial: 7951847
Drug: Omeprazole (OPZ)
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole (OPZ) 20 mg/day
Trial: 7951847
Drug: Omeprazole (OPZ)
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole (OPZ) 20 mg/day plus Pirenzepine (PZP) 100 mg/day
Trial: 26537478
Drug: L‐T4 administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L‐T4 administered at 0-10 min intervals before breakfast
Trial: 26537478
Drug: L‐T4 taken
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L‐T4 taken 30 min before breakfast
Trial: 27027878
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine (IGlar) once daily
Trial: 23393185
Drug: Insulin degludec
RxNorm normalized name: Insulin Degludec
DrugBank: Insulin degludec (DB09564)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Insulin degludec (IDeg) Free-Flex
Trial: 23393185
Drug: Insulin degludec
RxNorm normalized name: Insulin Degludec
DrugBank: Insulin degludec (DB09564)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Insulin degludec (IDeg) Forced-Flex
Trial: 23393185
Drug: Insulin degludec
RxNorm normalized name: Insulin Degludec
DrugBank: Insulin degludec (DB09564)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Insulin degludec (IDeg) and Insulin glargine (IGlar)
Trial: 18414107
Drug: Bimatoprost/timolol fixed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bimatoprost/timolol fixed combination (FC)
Trial: 15651517
Drug: Morphine 3
RxNorm normalized name: apomorphine 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 3 mg
Trial: 10781460
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of clonidine 1 microg/kg and morphine 3 mg
Trial: 19104775
Drug: Methylphenidate (MPH)
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylphenidate (MPH) 40 mg
Trial: 20937127
Drug: Minocycline 100
RxNorm normalized name: minocycline 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minocycline 100 mg or 200 mg daily
Trial: 18538109
Drug: CR002 (0.3,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CR002 (0.3, 1, 3, 10, 30 mg/kg)
Trial: 2052306
Drug: Balanced salt
RxNorm normalized name: Balanced Salt Solution
DrugBank: Magnesium chloride (DB09407)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Balanced salt solution (placebo)
Trial: 26260705
Drug: Intravenous ghrelin
RxNorm normalized name: Ghrelin
DrugBank: Lenomorelin (DB11895)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ghrelin at 1 μg/kg or 2 μg/kg, twice daily for 3 weeks
Trial: 26019878
Drug: 80% reduced
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80% reduced basal insulin dose with reduced prandial bolus insulin and LGI carbohydrate feeding
Trial: 31174360
Drug: 100% basal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100% basal insulin dose
Trial: 21228629
Drug: RIX4414 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RIX4414 vaccine stored at 2 °C‐8 °C (Group RIX4414_control, n = 171)
Trial: 21228629
Drug: RIX4414 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RIX4414 vaccine stored at 37 °C for 7 days (Group RIX4414_37 °C, n = 47)
Trial: 19480560
Drug: UK-453,061 (non-nucleoside
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UK-453,061 (non-nucleoside reverse transcriptase inhibitor)
Trial: 17541023
Drug: 17beta‐estradiol (0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17beta‐estradiol (0.05 mg/d)
Trial: 8852740
Drug: Glucose (isocaloric
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose (isocaloric completed nutritional solution)
Trial: 1519576
Drug: Cimetidine 800
RxNorm normalized name: cimetidine 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 800 mg evening dose
Trial: 1519576
Drug: Ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 300 mg evening dose
Trial: 1519576
Drug: Famotidine 40
RxNorm normalized name: famotidine 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famotidine 40 mg evening dose
Trial: 31475415
Drug: 1000 mg/day
RxNorm normalized name: RibaTab 1000 MG/day Compliance Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg/day trans‐resveratrol
Trial: 15741753
Drug: Satraplatin 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Satraplatin 100 mg/m² for 5 days plus prednisone 10 mg orally BID
Trial: 12393614
Drug: Mitoxantrone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mitoxantrone (10 mg/m² per day x 5) and Etoposide (100 mg/m² per day x 5)
Trial: 12393614
Drug: Cytarabine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytarabine (200 mg/m² per day x 7) and Daunorubicin (45 mg/m² per day x 3)
Trial: 10355069
Drug: Cordichin (fixed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cordichin (fixed combination of chinidin and verapamil)
Trial: 10355069
Drug: Chronic antiarrhythmic
RxNorm normalized name: Chromic Chloride
DrugBank: Chromic chloride (DB09129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chronic antiarrhythmic drug administration (Sotalol or Cordichin)
Trial: 10355069
Drug: Antiarrhythmic medication
RxNorm normalized name: ANTIARRHYTHMICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiarrhythmic medication (Sotalol or Cordichin)
Trial: 25782429
Drug: Topical fluoride
RxNorm normalized name: Carles 60 Second APF 1.23% Topical Fluoride Dental Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical fluoride application
Trial: 20299993
Drug: Intravenous opioids
RxNorm normalized name: OPIOIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous opioids (group O)
Trial: 17296819
Drug: Oral ferrous
RxNorm normalized name: ferrous fumarate Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ferrous sulfate 325 mg three times daily for 8 weeks
Trial: 12269969
Drug: Alicaforsen (ISIS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alicaforsen (ISIS 2302) 300 mg, infused intravenously three times a week for 4 weeks
Trial: 12269969
Drug: Alicaforsen (ISIS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alicaforsen (ISIS 2302) 350 mg, infused intravenously three times a week for 4 weeks
Trial: 12269969
Drug: Alicaforsen (ISIS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alicaforsen (ISIS 2302) 250 mg, infused intravenously for patients weighing 36-50 kg
Trial: 10194609
Drug: Sustained-release theophylline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release theophylline formulation (200 mg anhydrous theophylline)
Trial: 10194609
Drug: Market formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Market formulation (Theobid)
Trial: 8874661
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate 200 micrograms twice daily
Trial: 28258730
Drug: Alpha Lipoic
RxNorm normalized name: Alpha Lipoic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpha Lipoic Acid (ALA) oral supplementation
Trial: 26021488
Drug: DHA+EPA (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA+EPA (4 g/day)
Trial: 15871484
Drug: 5-HT2A inhibitor
RxNorm normalized name: Fibrinolysis inhibitor
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 5-HT2A inhibitor (sarpogrelate 300 mg/day)
Trial: 15871484
Drug: NSAIDs (diclofenac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NSAIDs (diclofenac 75 mg/day)
Trial: 2856892
Drug: Nadolol 80
RxNorm normalized name: nadolol 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nadolol 80 mg
Trial: 6337412
Drug: Nadolol 160
RxNorm normalized name: nadolol 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nadolol 160 mg
Trial: 7936823
Drug: Protein intakes
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein intakes ranging from 2.25 to 3.9 g.kg‐1.d‐1 and energy intakes ranging from 115 to 147 kcal.kg‐1.d‐1
Trial: 8204277
Drug: Base cream
RxNorm normalized name: U-Base Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Base cream
Trial: 17719167
Drug: L-arginine (3g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (3g daily)
Trial: 9167772
Drug: Single-drug parenteral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-drug parenteral polyestradiol phosphate (240 mg intramuscularly every second week for the first two months, then every fourth week)
Trial: 24289108
Drug: Dasatinib 100
RxNorm normalized name: dasatinib 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dasatinib 100 mg once daily (QD)
Trial: 22781199
Drug: Nebulized 0.5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized 0.5% salbutamol (150 µg/kg) + 0.025% ipratropium bromide (1 ml) + saline (2 ml)
Trial: 14748763
Drug: Dronedarone 800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dronedarone 800 mg
Trial: 14748763
Drug: Dronedarone 1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dronedarone 1200 mg
Trial: 14748763
Drug: Dronedarone 1600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dronedarone 1600 mg
Trial: 14748763
Drug: Dronedarone (800‐1600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dronedarone (800‐1600 mg daily) added to metoprolol (200 mg daily)
Trial: 11606503
Drug: High-dose UDCA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose UDCA (20 mg/kg daily)
Trial: 9587719
Drug: Buprenorphine 0.3
RxNorm normalized name: buprenorphine 0.3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine 0.3 mg plus ketoprofen 100 mg and propacetamol 2 g (group 3)
Trial: 2683824
Drug: Nimodipine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimodipine (2 mg.h‐1)
Trial: 24850775
Drug: 15 mL
RxNorm normalized name: ethanol 0.15 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mL of 0.2% chlorhexidine (CHX) for 60 s as a rinse
Trial: 24850775
Drug: 15 mL
RxNorm normalized name: ethanol 0.15 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mL of 0.2% chlorhexidine (CHX) for 60 s as a swab
Trial: 24060277
Drug: White lupin
RxNorm normalized name: White Petrolatum
DrugBank: Petrolatum (DB11058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: White lupin fibre (25 g/d)
Trial: 24060277
Drug: Soya fibre
RxNorm normalized name: Fiore
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soya fibre (25 g/d)
Trial: 21288325
Drug: Standard Vietnamese
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard Vietnamese national guideline treatment for tuberculous meningitis
Trial: 21288325
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment plus high-dose rifampicin and levofloxacin
Trial: 15800226
Drug: Warfarin (target
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin (target international normalized ratio, 2.0 to 3.0)
Trial: 8550648
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Morphine and Methylprednisolone
Trial: 2191764
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy plus tamoxifen (RT-TAM)
Trial: 16864164
Drug: Postoperative radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative radiation therapy (RT)
Trial: 30088178
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy (CT)
Trial: 2191764
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy or tamoxifen
Trial: 30135176
Drug: CAR T-cell
RxNorm normalized name: CD123-CD33cCAR T-cells
DrugBank: ICG-136 (DB17343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CAR T-cell therapy with engineered multispecificity
Trial: 25802955
Drug: MT +
RxNorm normalized name: lipase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MT + MG
Trial: 16647411
Drug: intravenous immune
RxNorm normalized name: Intravenous immune globulin (human)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: intravenous immune globulin (IVIg) at 0.8 g/kg
Trial: 10966281
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of iNO and HV
Trial: 6407429
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg slow release isosorbide dinitrate (ISDN group)
Trial: 6407429
Drug: 7.5 mg
RxNorm normalized name: biotin 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 mg slow release nitroglycerin (NTG group)
Trial: 27184785
Drug: Ibuprofen IR/ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen IR/ER
Trial: 22371525
Drug: Daily electronic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily electronic transmission of body weight to HF clinic using an electronic scale.
Trial: 11032589
Drug: Tamoxifen 20
RxNorm normalized name: tamoxifen 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen 20 mg/d
Trial: 15699284
Drug: Transdermal estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal estrogen therapy with tamoxifen
Trial: 12818947
Drug: Propofol (100-200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (100-200 micro g x kg(‐1) x min(‐1)) with 60% N(2)O in O(2)
Trial: 11905407
Drug: Preoperative selective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative selective gut decontamination (SGD) with oral nonabsorbable antibiotics (polymyxin B and neomycin) for 5 to 7 days
Trial: 8751020
Drug: Oral atropine
RxNorm normalized name: atropine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral atropine (0.03 mg/kg)
Trial: 11348713
Drug: Split vaccine
RxNorm normalized name: INFLUENZA VIRUS,TRIVALENT SPLIT VACCINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Split vaccine
Trial: 24074027
Drug: E2 valerate
RxNorm normalized name: valerate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E2 valerate (4 mg/day) for 5-12 days
Trial: 19696205
Drug: Medical Nutrition
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical Nutrition Therapy (MNT) program
Trial: 17414703
Drug: Antilymphocyte globulin
RxNorm normalized name: antilymphocyte immunoglobulin
DrugBank: Antilymphocyte immunoglobulin (horse) (DB09312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antilymphocyte globulin (ALG) induction without steroids
Trial: 11528581
Drug: Infrequent monitoring
RxNorm normalized name: iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Infrequent monitoring (at baseline and twice yearly)
Trial: 9146258
Drug: Collaborative standardization
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Collaborative standardization of diagnosis and treatment of R/O sepsis patients
Trial: 3371082
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g or 10% fructose-1,6-diphosphate (FDP) twice daily for 7 to 10 days
Trial: 30582156
Drug: Cannabidiol (CBD)
RxNorm normalized name: cannabidiol (CBD)
DrugBank: Cannabidiol (DB09061)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Cannabidiol (CBD) treatment
Trial: 26952547
Drug: Tocilizumab (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocilizumab (8 mg/kg) plus oral prednisolone
Trial: 23656601
Drug: Exercise therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise therapy (ET) - jaw movement exercise (JME)
Trial: 23656601
Drug: Exercise therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise therapy (ET) - jaw movement exercise (JME) and psychological intervention (PI)
Trial: 23656601
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group - pharmacological treatment only
Trial: 18355411
Drug: Korean pine
RxNorm normalized name: Korean ginseng root
DrugBank: Ginseng (DB01404)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Korean pine nut FFA (3 g)
Trial: 18355411
Drug: Korean pine
RxNorm normalized name: Korean ginseng root
DrugBank: Ginseng (DB01404)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Korean pine nut TG (3 g)
Trial: 15735101
Drug: Soy protein
RxNorm normalized name: Soy Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy protein (26.6 +/- 4.5 g protein/d containing 44.4 +/- 7.5 mg isoflavones/d)
Trial: 15735101
Drug: Milk protein
RxNorm normalized name: Milk protein
DrugBank: Casein (DB10516)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk protein (26.6 +/- 4.5 g protein/d)
Trial: 3688595
Drug: Super-Char (57.76%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Super-Char (57.76% reduction in aspirin absorption)
Trial: 3688595
Drug: Actidose-Aqua (50.42%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Actidose-Aqua (50.42% reduction in aspirin absorption)
Trial: 31408152
Drug: Patient compliance
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient compliance with drug use
Trial: 26228536
Drug: Acceptance-Based Behavior
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acceptance-Based Behavior Therapy (ABBT)
Trial: 22019148
Drug: Sham injections
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham injections (dilute blood)